Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery

Hatem Zayed, Lily Xia, Anton Yerich, Stephen R. Yant, Mark A. Kay, M. Puttaraju, Gerard J. McGarrity, David L. Wiest, R. Scott McIvor, Jakub Tolar, Bruce R. Blazar

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Spliceosome-mediated RNA trans-splicing (SMaRT) is an emerging technology for the repair of defective pre-messenger RNA (pre-mRNA) molecules. It is especially useful in the treatment of genetic disorders involving large genes. Although viral vectors have been used for achieving long-lasting expression of trans-splicing molecules, the immunogenicity and suboptimal safety profiles associated with viral-based components could limit the widespread application of SMaRT in the repair of genetic defects. Here, we tested whether the non-viral Sleeping Beauty (SB) transposon system could mediate stable delivery of trans-splicing molecules designed to correct the genetic defect responsible for severe combined immune deficiency (SCID). This immunological disorder is caused by a point mutation within the 12.4 kilobase (kb) gene encoding the DNA protein kinase catalytic subunit (DNA-PKcs) and is associated with aberrant DNA repair, defective T- and B-cell production, and hypersensitivity to radiation-induced injury. Using a novel SB-based trans-splicing vector, we demonstrate stable mRNA correction, proper DNA-PKcs protein production, and conference of a radiation-resistant phenotype in a T-cell thymoma cell line and SCID multipotent adult progenitor cells (MAPCs). These results suggest that SB-based trans-splicing vectors should prove useful in facilitating the correction of endogenous mutated mRNA transcripts, including the DNA-PKcs defect present in SCID cells.

Original languageEnglish (US)
Pages (from-to)1273-1279
Number of pages7
JournalMolecular Therapy
Volume15
Issue number7
DOIs
StatePublished - Jul 1 2007

Fingerprint

Trans-Splicing
Polynucleotide 5'-Hydroxyl-Kinase
Spliceosomes
Beauty
Protein Deficiency
Protein Kinases
Severe Combined Immunodeficiency
Catalytic Domain
Messenger RNA
Viral Structures
Radiation Injuries
Inborn Genetic Diseases
Thymoma
Point Mutation
DNA Repair
Genes
Hypersensitivity
B-Lymphocytes
Stem Cells
Radiation

Cite this

Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery. / Zayed, Hatem; Xia, Lily; Yerich, Anton; Yant, Stephen R.; Kay, Mark A.; Puttaraju, M.; McGarrity, Gerard J.; Wiest, David L.; McIvor, R. Scott; Tolar, Jakub; Blazar, Bruce R.

In: Molecular Therapy, Vol. 15, No. 7, 01.07.2007, p. 1273-1279.

Research output: Contribution to journalArticle

Zayed, Hatem ; Xia, Lily ; Yerich, Anton ; Yant, Stephen R. ; Kay, Mark A. ; Puttaraju, M. ; McGarrity, Gerard J. ; Wiest, David L. ; McIvor, R. Scott ; Tolar, Jakub ; Blazar, Bruce R. / Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery. In: Molecular Therapy. 2007 ; Vol. 15, No. 7. pp. 1273-1279.
@article{aa64317e001d47aaaf197fb6578fbcaf,
title = "Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery",
abstract = "Spliceosome-mediated RNA trans-splicing (SMaRT) is an emerging technology for the repair of defective pre-messenger RNA (pre-mRNA) molecules. It is especially useful in the treatment of genetic disorders involving large genes. Although viral vectors have been used for achieving long-lasting expression of trans-splicing molecules, the immunogenicity and suboptimal safety profiles associated with viral-based components could limit the widespread application of SMaRT in the repair of genetic defects. Here, we tested whether the non-viral Sleeping Beauty (SB) transposon system could mediate stable delivery of trans-splicing molecules designed to correct the genetic defect responsible for severe combined immune deficiency (SCID). This immunological disorder is caused by a point mutation within the 12.4 kilobase (kb) gene encoding the DNA protein kinase catalytic subunit (DNA-PKcs) and is associated with aberrant DNA repair, defective T- and B-cell production, and hypersensitivity to radiation-induced injury. Using a novel SB-based trans-splicing vector, we demonstrate stable mRNA correction, proper DNA-PKcs protein production, and conference of a radiation-resistant phenotype in a T-cell thymoma cell line and SCID multipotent adult progenitor cells (MAPCs). These results suggest that SB-based trans-splicing vectors should prove useful in facilitating the correction of endogenous mutated mRNA transcripts, including the DNA-PKcs defect present in SCID cells.",
author = "Hatem Zayed and Lily Xia and Anton Yerich and Yant, {Stephen R.} and Kay, {Mark A.} and M. Puttaraju and McGarrity, {Gerard J.} and Wiest, {David L.} and McIvor, {R. Scott} and Jakub Tolar and Blazar, {Bruce R.}",
year = "2007",
month = "7",
day = "1",
doi = "10.1038/sj.mt.6300178",
language = "English (US)",
volume = "15",
pages = "1273--1279",
journal = "Molecular Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "7",

}

TY - JOUR

T1 - Correction of DNA protein kinase deficiency by spliceosome-mediated RNA trans-splicing and sleeping beauty transposon delivery

AU - Zayed, Hatem

AU - Xia, Lily

AU - Yerich, Anton

AU - Yant, Stephen R.

AU - Kay, Mark A.

AU - Puttaraju, M.

AU - McGarrity, Gerard J.

AU - Wiest, David L.

AU - McIvor, R. Scott

AU - Tolar, Jakub

AU - Blazar, Bruce R.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - Spliceosome-mediated RNA trans-splicing (SMaRT) is an emerging technology for the repair of defective pre-messenger RNA (pre-mRNA) molecules. It is especially useful in the treatment of genetic disorders involving large genes. Although viral vectors have been used for achieving long-lasting expression of trans-splicing molecules, the immunogenicity and suboptimal safety profiles associated with viral-based components could limit the widespread application of SMaRT in the repair of genetic defects. Here, we tested whether the non-viral Sleeping Beauty (SB) transposon system could mediate stable delivery of trans-splicing molecules designed to correct the genetic defect responsible for severe combined immune deficiency (SCID). This immunological disorder is caused by a point mutation within the 12.4 kilobase (kb) gene encoding the DNA protein kinase catalytic subunit (DNA-PKcs) and is associated with aberrant DNA repair, defective T- and B-cell production, and hypersensitivity to radiation-induced injury. Using a novel SB-based trans-splicing vector, we demonstrate stable mRNA correction, proper DNA-PKcs protein production, and conference of a radiation-resistant phenotype in a T-cell thymoma cell line and SCID multipotent adult progenitor cells (MAPCs). These results suggest that SB-based trans-splicing vectors should prove useful in facilitating the correction of endogenous mutated mRNA transcripts, including the DNA-PKcs defect present in SCID cells.

AB - Spliceosome-mediated RNA trans-splicing (SMaRT) is an emerging technology for the repair of defective pre-messenger RNA (pre-mRNA) molecules. It is especially useful in the treatment of genetic disorders involving large genes. Although viral vectors have been used for achieving long-lasting expression of trans-splicing molecules, the immunogenicity and suboptimal safety profiles associated with viral-based components could limit the widespread application of SMaRT in the repair of genetic defects. Here, we tested whether the non-viral Sleeping Beauty (SB) transposon system could mediate stable delivery of trans-splicing molecules designed to correct the genetic defect responsible for severe combined immune deficiency (SCID). This immunological disorder is caused by a point mutation within the 12.4 kilobase (kb) gene encoding the DNA protein kinase catalytic subunit (DNA-PKcs) and is associated with aberrant DNA repair, defective T- and B-cell production, and hypersensitivity to radiation-induced injury. Using a novel SB-based trans-splicing vector, we demonstrate stable mRNA correction, proper DNA-PKcs protein production, and conference of a radiation-resistant phenotype in a T-cell thymoma cell line and SCID multipotent adult progenitor cells (MAPCs). These results suggest that SB-based trans-splicing vectors should prove useful in facilitating the correction of endogenous mutated mRNA transcripts, including the DNA-PKcs defect present in SCID cells.

UR - http://www.scopus.com/inward/record.url?scp=34250739824&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250739824&partnerID=8YFLogxK

U2 - 10.1038/sj.mt.6300178

DO - 10.1038/sj.mt.6300178

M3 - Article

C2 - 17457319

AN - SCOPUS:34250739824

VL - 15

SP - 1273

EP - 1279

JO - Molecular Therapy

JF - Molecular Therapy

SN - 1525-0016

IS - 7

ER -